Affordable Access

deepdyve-link
Publisher Website

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.

Authors
  • Spinelli, Matthew A1
  • Glidden, David V2
  • Anderson, Peter L3
  • Gandhi, Monica1
  • McMahan, Vanessa M4
  • Defechereux, Patricia5
  • Schechter, Mauro6
  • Veloso, Valdiléa G7
  • Chariyalertsak, Suwat8
  • Guanira, Juan V9
  • Bekker, Linda-Gail10
  • Buchbinder, Susan P5
  • Grant, Robert M5
  • 1 Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco, California.
  • 2 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
  • 3 Department of Pharmaceutical Sciences, University of Colorado, Aurora, Colorado.
  • 4 Department of Health Services, University of Washington, Seattle, Washington.
  • 5 Department of Medicine, University of California, San Francisco, San Francisco, California.
  • 6 Department of Preventive Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. , (Brazil)
  • 7 Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Brazil. , (Brazil)
  • 8 Research Institute for Health Sciences and Faculty of Public Health, Chiang Mai University, Chiang Mai, Thailand. , (Thailand)
  • 9 Investigaciones Medicas en Salud, Lima, Peru. , (Peru)
  • 10 Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa. , (South Africa)
Type
Published Article
Journal
AIDS Research and Human Retroviruses
Publisher
Mary Ann Liebert
Publication Date
Sep 01, 2019
Volume
35
Issue
9
Pages
788–793
Identifiers
DOI: 10.1089/AID.2018.0297
PMID: 31119944
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Bone mineral density (BMD) declines due to tenofovir-containing pre-exposure prophylaxis (PrEP) have varied among PrEP demonstration projects, potentially related to variable adherence. Characterization of BMD changes in highly adherent individuals, estimated via tenofovir-diphosphate (TFV-DP) levels in dried blood spots (DBS), can assist clinicians when counseling patients. Cisgender men who have sex with men and transwomen in the optional dual-energy X-ray absorptiometry (DXA) substudy of a large, international, open-label PrEP demonstration project, the iPrEx-open-label extension (OLE) study underwent DXA scans and DBS collection every 24 weeks, with average weekly dosing adherence patterns (2, 4, and 7 doses/week) estimated from validated TFV-DP cut-offs. The mean percent BMD change was estimated in strata of average weekly adherence by using a linear mixed-effects model to calculate the BMD decline in highly adherent individuals on PrEP for the first time. DXA/DBS data were available for 254 individuals over a median of 24 weeks in iPrEx-OLE from June 2011 to December 2013. The percent decline in spine BMD was monotonically associated with strata of increasing average weekly adherence (p < .001 trend); the p value for trends using hip BMD measurements was .07. Individuals with estimated daily adherence experienced a 1.2% decrease in spine BMD and a 0.5% drop in hip BMD. In highly adherent PrEP users, we found a lower-than-expected drop in BMD when compared with previous studies. This drop is likely not clinically significant for most PrEP users. However, for those at the highest risk of fracture who plan prolonged PrEP use, alternate PrEP strategies could be considered.

Report this publication

Statistics

Seen <100 times